Celularity Inc. (CELU)
NASDAQ: CELU · Real-Time Price · USD
2.040
-0.040 (-1.92%)
At close: Oct 7, 2025, 4:00 PM EDT
2.010
-0.030 (-1.47%)
After-hours: Oct 7, 2025, 5:54 PM EDT
Celularity Market Cap
Celularity has a market cap or net worth of $54.45 million as of October 7, 2025. Its market cap has decreased by -16.89% in one year.
Market Cap
54.45M
Enterprise Value
123.74M
1-Year Change
-16.89%
Ranking
Category
Stock Price
$2.04
Market Cap Chart
Since August 8, 2019, Celularity's market cap has decreased from $352.19M to $54.45M, a decrease of -84.54%. That is a compound annual growth rate of -26.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2025 | 54.45M | 16.43% |
| Dec 31, 2024 | 46.77M | -1.00% |
| Dec 29, 2023 | 47.24M | -74.75% |
| Dec 30, 2022 | 187.07M | -70.41% |
| Dec 31, 2021 | 632.14M | 59.91% |
| Dec 31, 2020 | 395.31M | 10.55% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Aug 8, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 758.63B |
| Johnson & Johnson | 453.15B |
| AbbVie | 406.64B |
| UnitedHealth Group | 324.93B |
| Novo Nordisk | 269.41B |
| AstraZeneca | 265.89B |
| Novartis AG | 257.47B |
| Abbott Laboratories | 232.77B |